Insiders Valerio Therapeutics Börse Stuttgart

Equities

Market Closed - Börse Stuttgart Other stock markets 06:47:50 04/07/2024 pm IST			5-day change	1st Jan Change
0.09 ^EUR	-1.10%		-1.09%	-40.13%

22/05	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
30/04	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Biophytis' Finance Chief Resigns; Onxeo Exec Named Successor	02/23/02	MT
Onxeo S.A. Appoints Khalil Barrage as New Board Member	16/22/16	CI
French Biotechnology Company Onxeo Names Chair as President/CEO	07/22/07	MT
Onxeo S.A. Announces the Appointment of Dr. Shefali Agarwal as President	07/22/07	CI
Onxeo S.A. Announces Executive Changes	07/22/07	CI
Onxeo Names Interim CEO	04/22/04	MT
Onxeo S.A. Appoints Julien Miara as Interim CEO	04/22/04	CI
Onxeo SA Appoints Bryan Giraudo as Independent Member of its Board of Directors Replacing Thomas Hofstaetter	23/21/23	CI
Onxeo SA Announces Board Appointments	14/21/14	CI
Onxeo S.A. Announces Appointment of Shefali Agarwal as the Chairwoman of the Board	29/21/29	CI
Onxeo S.A. Announces Board Changes	11/21/11	CI
Onxeo SA Announces Formation of Scientific Advisory Committee of Leading Independent Experts	31/21/31	CI
Onxeo SA Announces Board Changes	17/20/17	CI
Onxeo SA Announces Executive Changes	22/19/22	CI
Onxeo S.A. Establishes Scientific Advisory Board	28/17/28	CI
Onxeo SA Announces Executive Appointments	27/17/27	CI
Onxeo Announces Executive Appointments	01/17/01	CI
Onxeo Announces Establishment of U.S. Subsidiary; Appoints Philippe Maitre to Head U.S. Subsidiary	21/16/21	CI
Onxeo Announces Board Changes	25/16/25	CI
Onxeo SA Announces Board Changes	06/15/06	CI

No results for this search